Abstract CT014: Phase I dose-escalation study of fractionated dose 225Ac J591 for metastatic castration resistant prostate cancer

Overview of attention for article published in Cancer Research, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Dimensions has found 2 publications that cite this research output.

Article in Theranostics (January 2024)

Article in Cancers (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.